Tag: veterans

Veteran Affairs Official Who Tried to Ban V-J Photo Has Controversial Past

The U.S. Department of Veterans Affairs (VA) official who attempted to ban the iconic photograph of a U.S. Navy sailor kissing a nurse on V-J Day from VA hospitals has a controversial history of hospital mismanagement, reports have revealed.

Assistant Under Secretary for Health Operations RimaAnn Nelson became the center of a national controversy for sending out a memo to VA health providers demanding the “removal and replacement of ‘V-J in Times Square’ photographs” on February 29.

The letter leaked to social media earlier this week, prompting backlash from thousands who don’t agree with Nelson’s assertion that the nearly 80-year-old image violates “the VA’s no-tolerance policy towards domestic violence, sexual harassment, and assault.”

Nelson’s censorship bid caused such a firestorm that VA Secretary Denis McDonough made a statement rescinding the rule change.

“Let me be clear: This image is not banned from VA facilities — and we will keep it in VA facilities,” he wrote on X Tuesday.

Keep reading

Homelessness Rises Among US Veterans For 1st Time In 12 Years As Immigration Crisis Escalates

As national, state, and local governments continue to spend billions of dollars to house, feed, clothe, and provide medical care for millions of illegal immigrants, homelessness among U.S. veterans has risen dramatically for the first time in 12 years.

A recent report from the Department of Housing and Urban Development (HUD) details a 7.4 percent increase in veteran homelessness between 2022 and 2023 and estimates that more than 35,000 veterans are homeless on any given night. Over the course of a year, according to the report, almost twice as many veterans may experience homelessness. In total, HUD estimates that nearly 13 percent of the homeless adult population are veterans.

Kate Monroe, a U.S. Marine Corps veteran and CEO of VetComm.us, calls this situation “the ultimate betrayal” by the U.S. government. She is also a California Republican congressional candidate.

“What they are trying to do is get as many people into the U.S. as they can,” she told The Epoch Times. “And what we’re saying to our homeless veterans is that we as a country don’t care. It’s no wonder why recruiting is down by 20 percent.”

According to a November 2023 report by the Homeland Security Republican Committee, the money spent on illegal migrants could cost Americans up to $451 billion by the end of this year. According to NYC.gov, the official website for New York City, the Big Apple alone doled out $1.45 billion in 2023 to provide food, shelter, and services to tens of thousands of immigrants. Several published reports indicate that Chicago paid $138 million during the past year to house, feed, and care for illegal immigrants.

The Federation for American Immigration Reform reports that the state of California, which had the highest number of immigrants in 2023—more than 160,000—spent some $22.8 billion for their care in 2023. California has also become the first state to offer health insurance for all illegal immigrants.

Keep reading

Missouri Lawmakers Approve Bill To Legalize Psilocybin Therapy For Veterans

A Missouri House committee has unanimously approved a bill to legalize the medical use of psilocybin by military veterans and fund studies exploring the therapeutic potential of the psychedelic.

The House Veterans Committee passed the legislation from Rep. Aaron McMullen (R) on Tuesday, with amendments to align it with a Senate companion version that moved through a panel in that chamber last week.

The revised bill text of the House measure—which received an initial committee hearing last month—hasn’t been published yet, but the Senate version as recently amended would allow military veterans who are at least 21 and are diagnosed with a qualifying condition such as post-traumatic stress disorder (PTSD) or substance use disorders to legally access laboratory-tested psilocybin.

In order to receive legal protections under the legislation, participants would need to be enrolled, or have sought enrollment, in a study involving the psychedelic.

There are also numerous requirements for patients to provide the state Department of Mental Health (DMH) with information about their diagnosis, the person who would be administering psilocybin and other details on the place and time of the treatment sessions.

Psilocybin could only be administered over a maximum of a one-year period, with the amount of the psychedelic used in that treatment capped at 150 milligrams, though qualifying patients could be also approved to continue for subsequent one-year periods.

Regulators, physicians and state agency officials would all be protected from legal consequences related to activity made lawful under the legislation.

Also, the legislation calls for DMH to provide funding to support research into the therapeutic potential of psilocybin.

Keep reading

US govt. claims immunity from dozens of PFAS lawsuits, citing Federal Tort Claims Act

The United States government has asked a federal judge to dismiss more than two dozen lawsuits filed against it for allegedly contaminating water and soil at hundreds of sites near military bases and facilities across the country with toxic “forever chemicals.”

The U.S. told a federal judge in Charleston, South Carolina, late Monday that it is immune to the lawsuits filed by state and local governments, businesses and property owners who say the U.S. military is liable for property and environmental damage caused by its use of firefighting foams containing per- and polyfluoroalkyl substances, or PFAS.

PFAS are used in hundreds of consumer and commercial products including the firefighting foams, non-stick pans, stain-resistant clothing and cosmetics, and have been linked to cancer and hormonal dysfunction. The military has used PFAS-containing firefighting foams since the 1970s for things like firefighting training.

The chemicals are often referred to as forever chemicals because they do not easily break down in nature or in the human body.

The 27 lawsuits were filed in the past six years against the U.S. government by states including New Mexico, New York and Washington, cities, private property owners and local businesses near military facilities where firefighting foams were used.

The plaintiffs say they are seeking potentially hundreds of billions of dollars in damages to pay for groundwater and soil remediation near military sites across the country. Some businesses among the plaintiffs, including a dairy that claims PFAS-contaminated water caused its cattle to die and a property owner whose blueberry cropland was allegedly damaged by the chemicals, are also seeking punitive damages.

The government said it was immune to the lawsuits under a provision of the Federal Tort Claims Act that protects it from tort liability for the discretionary acts of government employees. That law allows plaintiffs to sue the U.S. government for damages only if the government violates specific, mandatory policies.

Military Veterans Who Received Psychedelic Ibogaine Treatment Saw ‘Dramatic’ And ‘Life-Changing’ Improvements In PTSD And Depression, Stanford Study Finds

Military combat veterans with traumatic brain injuries (TBI) saw “dramatic” and “life-changing” improvements in their symptoms and cognitive functioning immediately after receiving treatment with the psychedelic ibogaine, new research shows.

Stanford University researchers behind the study, which was published in the journal Nature Medicine last week, followed 30 veterans who were functionally disabled from symptoms of TBI such as post-traumatic stress, depression and anxiety and who had a history of repeated blast or combat exposures.

The team, which collaboration with the foundation VETS, Inc., assessed the veterans before and after they visited a clinic in Mexico to receive ibogaine treatment, and they identified profound changes in the participants’ mental health, with minimal side effects.

Prior to the treatment, the veterans each met the criteria for clinically significant levels of disability. Twenty-three had diagnosable PTSD, 14 had anxiety disorder, 15 had alcohol use disorder and 19 had been suicidal at some point in their lifetimes.

After receiving ibogaine, in addition to magnesium to protect against potential heart-related complications, there was an immediate “remarkable reduction” in symptoms, “with large effect sizes” that sustained over time.

Keep reading

Most Military Service Members, Veterans And Their Families Support Allowing VA Doctors To Recommend Marijuana And Psychedelics

Active duty military personnel, veterans and their family members support allowing U.S. Department of Veterans Affairs (VA) doctors to recommend medical marijuana and psychedelics to patients if they believe it would provide a benefit, according to results of a survey from Ohio State University (OSU).

Researchers polled service members, veterans, their family members and non-military respondents over a few weeks in late August and early September, the report says. All told, 1,168 individuals participated, including 315 active and veteran military members, 426 members of military families and 427 non-military individuals. The goal was to assess the differing likelihoods across the categories of respondents to support various statements about medical marijuana and psychedelics as available treatment options.

“Given the prevalence of health issues within the veteran community and the need for a wide range of treatment options, some researchers have started to explore whether and how veteran populations should have access to alternative treatment options such as marijuana and psychedelics,” authors wrote in the preprint paper, which was published this month by OSU law school’s Drug Enforcement and Policy Center and has not been peer-reviewed. “Studies of veteran views on these issues, however, have not closely explored how veteran perspectives on certain drug issues compare directly to those in their immediate and broader community.”

The survey participants, drawn from the volunteer American Population Panel, were asked whether they agreed or disagreed with four statements about marijuana and psychedelics:

  1. Marijuana/psychedelics can be an effective treatment for various medical conditions.
  2. A doctor should be legally allowed to recommend marijuana/psychedelics if the doctor believes the patient could benefit from medical marijuana/psychedelics, even without FDA approval.
  3. A doctor should be legally allowed to recommend marijuana/psychedelics, but only after it has received an approval by the U.S. Food and Drug Administration.
  4. Because of the unique hardships and health conditions experienced by veterans, U.S. Veterans Administration doctors should be legally allowed to recommend marijuana/psychedelics to veterans if the doctor believes the patient could benefit from marijuana/psychedelics.

Strong majorities of all three surveyed groups agreed the substances can be effective treatments, with even more sizable proportions saying that Veterans Administration (VA) doctors should be able to legally recommend the substances to patients if they believe they would provide some benefit.

Keep reading

New York Bill Would Create Psilocybin Therapy Pilot Program For 10,000 Military Veterans And First Responders

A New York lawmaker has introduced a bill that would create a pilot program to provide psilocybin therapy to 10,000 people, focusing on military veterans and first responders, while the legislature also considers broader psychedelics reform.

Assemblymember Pat Burke (D), who has championed various psychedelics measures over recent sessions, filed the therapeutic psilocybin pilot program legislation on Wednesday.

It would create the program under the state Department of Health, which would be required to provide funding to cover the therapy and develop training guidelines for professional facilitators. It would need to issue a report on findings and policy recommendations to the governor and legislature every two years after enactment.

A total of 10,000 patients could participate, including veterans and their families, first responders and people who suffer from cluster headaches. They would need to reside in the western region of New York.

The pilot program would end if psilocybin is approved for medical use by the federal Food and Drug Administration (FDA).

“Psilocybin therapy offers serious potential benefits to assist with mental health, but it suffers from a lack of substantial medical testing,” a memo attached to the measure says. “This bill would alleviate that problem by establishing a pilot program to test psilocybin therapy’s effectiveness on mental health.”

“This pilot program would help record the effects of this treatment on their conditions in order to better understand the effects of this new therapy which promises substantial benefits,” it says.

Under the legislation, the health department would be able to enter into agreements with experts, non-profit organizations, universities or other institutions “for the performance of an evaluation of the implementation and effectiveness” of the program.

Keep reading

CONGRESS IS PUSHING REVOLUTIONARY RESEARCH ON PSYCHEDELIC TREATMENTS FOR THE MILITARY

CONGRESS IS ON track to approve legislation that would mark a significant advance in U.S. policy toward psychedelics. 

Tucked into the National Defense Authorization Act of 2024 is a provision to fund clinical trials using psychedelic substances to treat active duty members of the military.

Section 723 of the NDAA directs the secretary of defense to partner with a federal or state government agency, or an academic institution, to carry out the research. The bill would fund the treatment of members of the military with post-traumatic stress or a traumatic brain injury with a number of psychedelic substances, including MDMA, psilocybin, ibogaine, DMT, and other plant-based alternative therapies (such as ayahuasca).

Research surrounding psychedelics as a possible treatment for post-traumatic stress disorder have slowly grown, and recent studies have shown promising results, with patients benefiting from even just a few treatments including MDMA and psilocybin. Already, the Food and Drug Administration has designated both treatments as “breakthrough therapies”: a special designation given to expedite the research and development into drugs with the potential to treat serious conditions. On Tuesday, MAPS Public Benefit Corporation, which focuses on psychedelic treatments for mental health issues, submitted a new drug application to the FDA for MDMA-assisted therapy for PTSD. The company says it’s the first such submission for any psychedelic-assisted therapy.

Keep reading

House And Senate Reach Deal To Require Psychedelics Clinical Trials For Active Duty Military Service Members Under Defense Bill

Bipartisan and bicameral congressional lawmakers have reached an agreement on a large-scale defense bill that contains a House GOP-led section to fund studies into the therapeutic use of psychedelics such as psilocybin and MDMA for military service members.

Following negotiations, lawmakers released the conference report for the 2024 National Defense Authorization Act (NDAA) on Wednesday evening, maintaining psychedelics research provisions championed by Rep. Morgan Luttrell (R-TX) that were attached to the House version over the summer. The report notes, however, that the House negotiators receded on a separate section to create a medical cannabis pilot program for veterans.

The psychedelics provisions that have been adopted would require the Department of Defense (DOD) to establish a process by which service members with post-traumatic stress disorder (PTSD) or traumatic brain injury could participate in clinical trials involving psilocybin, MDMA, ibogaine and 5-MeO-DMT. The list of covered psychedelics was also expanded to broadly include “qualified plant-based alternative therapies.”

DOD would need to facilitate that process within 180 days of enactment. It could partner with eligible federal or state government agencies, as well as academic institutions to carry out the clinical trials, with $10 million in funding.

Keep reading

US govt-linked Ukraine activists hold pro-Nazi Veterans Day rally outside White House

A recent rally in front of the White House featuring Nazi iconography has been wholly ignored by the same mainstream media outlets pushing the narrative of rising antisemitism. The two DC-based organizations behind the events collaborated with the Biden administration on a similar event last February.

This Veterans Day, on November 11, passersby outside the White House gates were met with the sight of protest signs bearing Nazi-inspired Wolfsangels and protesters performing fascist salutes.

While the rally may have fallen under the radar of the mainstream press – or was deliberately ignored – the US-government owned Voice of America (VOA) provided extensive coverage through their Ukraine branch. One photograph embedded in the story features Ukraine war veteran Roman Kashpur flanked by the White House and performing a fascist salute. Astonishingly, the second shot of the outlet’s video report features a Wolfsangel. Rally goers chanted “bring our heroes home!” and “Make Russia pay!”

VOA interviewed the rally’s organizer, Nadiya Shaporynska, whose talking points sounded as though they could have come from the Ukrainian embassy itself: “Our main message today is a call for the release of prisoners-defenders of Azovstal. We are now asking the United States for help to free them as soon as possible.”

Shaporynska has collaborated directly with the Biden Administration during past initiatives. As revealed in The Grayzone, she and a coterie of activists with longstanding ties to neo-Nazi militias managed to arrange for high-level Biden Administration officials to speak at a rally this past February.

Keep reading